MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/02656736.2020.1780328

Медицинская библиотека · International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2020

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.

Tan Wei Phin, Chang Andrew, Brousell Steven C, Grimberg Dominic C, Fantony Joseph J, Longo Thomas A, Etienne Wiguins, Spasojevic Ivan, Maccarini Paolo, Inman Brant A

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Hyperthermia (heating to 43 °C) activates the innate immune system and improves bladder cancer chemosensitivity.

OBJECTIVE

To evaluate the tissue penetration and safety of convective hyperthermia combined with intravesical mitomycin C (MMC) pharmacokinetics in live porcine bladder models using the Combat bladder recirculation system (BRS).

METHODS

Forty 60 kg-female swine were anesthetized and catheterized with a 3-way, 16 F catheter. The Combat device was used to heat the bladders to a target temperature of 43 °C with recirculating intravesical MMC at doses of 40, 80, and 120 mg. Dwell-heat time varied from 30-180 min. Rapid necropsy with immediate flash freezing of tissues, blood and urine occurred. MMC concentrations were measured by liquid chromatography tandem-mass spectrometry.

RESULTS

The Combat BRS system was able to achieve target range temperature (42-44 °C) in 12 mins, and this temperature was maintained as long as the device was running. Two factors increased tissue penetration of MMC in the bladder: drug concentration, and the presence of heat. In the hyperthermia arm, MMC penetration saturated at 80 mg, suggesting that with heating, drug absorption may saturate and not require higher doses to achieve the maximal biological effect. Convective hyperthermia did not increase the MMC concentration in the liver, heart, kidney, spleen, lung, and lymph node tissue even at the 120 mg dose.

CONCLUSIONS

Convective bladder hyperthermia using the Combat BRS device is safe and the temperature can be maintained at 43 °C. Hyperthermia therapy may increase MMC penetration into the bladder wall but does not result in an increase of MMC levels in other organs.

Для цитирования: Tan Wei Phin, Chang Andrew, Brousell Steven C, Grimberg Dominic C, Fantony Joseph J, Longo Thomas A, Etienne Wiguins, Spasojevic Ivan, Maccarini Paolo, Inman Brant A. Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study.. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group. 2020. DOI: 10.1080/02656736.2020.1780328.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.